218 related articles for article (PubMed ID: 22277398)
1. [The pathophysiology and treatment of autoimmune neuromuscular junction diseases].
Motomura M
Rinsho Shinkeigaku; 2011 Nov; 51(11):872-6. PubMed ID: 22277398
[TBL] [Abstract][Full Text] [Related]
2. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
[TBL] [Abstract][Full Text] [Related]
3. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
Kitanosono H; Shiraishi H; Motomura M
Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
[TBL] [Abstract][Full Text] [Related]
4. [Lambert-Eaton myasthenic syndrome].
Motomura M; Fukuda T
Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
[TBL] [Abstract][Full Text] [Related]
5. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
[TBL] [Abstract][Full Text] [Related]
7. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
9. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
Schoser B; Eymard B; Datt J; Mantegazza R
J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia.
van Sonderen A; Wirtz PW; Verschuuren JJ; Titulaer MJ
Curr Treat Options Neurol; 2013 Apr; 15(2):224-39. PubMed ID: 23263888
[TBL] [Abstract][Full Text] [Related]
11. [Editorial introduction: from the structure and functions of the neuromuscular junction to the diseases].
Takamori M
Brain Nerve; 2011 Jul; 63(7):635-40. PubMed ID: 21747132
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune mediated neuromuscular junction defects.
Farrugia ME; Vincent A
Curr Opin Neurol; 2010 Oct; 23(5):489-95. PubMed ID: 20651592
[TBL] [Abstract][Full Text] [Related]
13. [Lambert-Eaton myasthenic syndrome (LEMS)].
Suzuki S
Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
[TBL] [Abstract][Full Text] [Related]
14. Clinical aspects of neuromuscular transmission disorders.
Evoli A
Acta Neurol Scand Suppl; 2006; 183():8-11. PubMed ID: 16637919
[TBL] [Abstract][Full Text] [Related]
15. Update in the Management of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.
Bodkin C; Pascuzzi RM
Neurol Clin; 2021 Feb; 39(1):133-146. PubMed ID: 33223079
[TBL] [Abstract][Full Text] [Related]
16. [Lambert-Eaton Myasthenic Syndrome].
Matsuo H
Brain Nerve; 2024 May; 76(5):630-634. PubMed ID: 38741506
[TBL] [Abstract][Full Text] [Related]
17. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
Honnorat J
Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
[TBL] [Abstract][Full Text] [Related]
18. Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Rev Neurol (Paris); 2004 Feb; 160(2):177-80. PubMed ID: 15034474
[TBL] [Abstract][Full Text] [Related]
19. Voltage gated calcium channel antibody-related neurological diseases.
Bekircan-Kurt CE; Derle Çiftçi E; Kurne AT; Anlar B
World J Clin Cases; 2015 Mar; 3(3):293-300. PubMed ID: 25789302
[TBL] [Abstract][Full Text] [Related]
20. Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Miralles F
Med Biol Eng Comput; 2016 Nov; 54(11):1761-1778. PubMed ID: 27016366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]